AI assistant
Sending…
CME GROUP INC. — Director's Dealing 2023
Mar 29, 2023
29871_dirs_2023-03-29_a9f8b628-ad02-403b-bee4-08816060a8df.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2022-12-28
Reporting Person: SHEPARD WILLIAM R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-12-28 | Common Stock Class A | P | 12.757 | $168.11 | Acquired | 2157.288 | Direct |
| 2022-12-28 | Common Stock Class A | P | 289.366 | $168.11 | Acquired | 248132.061 | Indirect |
| 2023-01-18 | Common Stock Class A | P | 54.839 | $175.98 | Acquired | 2212.127 | Direct |
| 2023-01-18 | Common Stock Class A | P | 1243.923 | $175.98 | Acquired | 249570.676 | Indirect |
Footnotes
F1: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker.
F2: This Form 4/A is being filed solely to correct the number of securities held indirectly following this purchase.
More from CME GROUP INC.
Proxy Solicitation & Information Statement
2026
May 19
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
Apr 24
Regulatory Filings
2026
Apr 22
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 23
Annual Report
2026
Mar 23
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 19
Regulatory Filings
2026
Mar 17